<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01106547</url>
  </required_header>
  <id_info>
    <org_study_id>Hysterektomistudiet</org_study_id>
    <secondary_id>SJ-127</secondary_id>
    <secondary_id>2010-018448-15</secondary_id>
    <nct_id>NCT01106547</nct_id>
  </id_info>
  <brief_title>The Effect of a Preoperative Single-dose Methylprednisolone on the Postoperative Rehabilitation After Abdominal Hysterectomy</brief_title>
  <official_title>The Effect of a Preoperative Single-dose Methylprednisolone on the Postoperative Rehabilitation After Abdominal Hysterectomy: A Prospective, Double Blinded, Placebo Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Holbaek Sygehus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Holbaek Sygehus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effect of 125 mg methylprednisolone, given
      intravenously 60-90 minutes before abdominal surgery,on the postoperative rehabilitation
      after abdominal hysterectomy.Sodium Chloride is the placebo. The following parameters are
      registered:

        1. Pain 3, 6 and 24 hours postoperatively and 2-7 days after surgery.

        2. The postoperative use of additional analgesics.

        3. Inflammatory parameters before and after surgery.

        4. Time until mobilization.

        5. Time until discharge.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain 6 hours postoperatively</measure>
    <time_frame>6 hours postoperatively</time_frame>
    <description>Pain registered by a score on a vas-scale from 0-10 during mobilization and during rest 6 hours postoperatively</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain 3 hours postoperatively</measure>
    <time_frame>3 hours postoperatively</time_frame>
    <description>Pain registered by a score on a vas-scale from 0-10 during mobilization and during rest 3 hours postoperatively</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain 24 hours postoperatively</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>Pain registered by a score on a vas-scale from 0-10 during mobilization and during rest 24 hours postoperatively</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>2-7 days postoperatively</time_frame>
    <description>Pain registered by a score on a vas-scale from 0-10 during mobilization and during rest once daily from 2nd-7th postoperative day</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Use of additional analgesics</measure>
    <time_frame>0-2 days</time_frame>
    <description>The use of other analgesics than paracetamol and diclofenac postoperatively - dosage.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea</measure>
    <time_frame>until 2 days postoperatively</time_frame>
    <description>Numbers of vomits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of antiemetics</measure>
    <time_frame>0-2 days postoperatively</time_frame>
    <description>Dosage of antiemetics during the first 2 days postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time until mobilization</measure>
    <time_frame>0-2 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time until discharge after surgery</measure>
    <time_frame>0-10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory parameters</measure>
    <time_frame>0-24 h preoperatively</time_frame>
    <description>CRP measured 0-24 hours preoperatively before injection of project medicine.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse effects</measure>
    <time_frame>0-2 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory parameter</measure>
    <time_frame>1-2 days postoperative</time_frame>
    <description>CRP measured at 10am on the first and second postoperative day.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">55</enrollment>
  <condition>Hysterectomy</condition>
  <condition>Methylprednisolone</condition>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Methylprednisolone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo/sodium chloride</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methylprednisolone 125mg</intervention_name>
    <description>Single dose 60-90 minutes preoperatively</description>
    <arm_group_label>Methylprednisolone</arm_group_label>
    <other_name>Solu-medrol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium Chloride 2 ml</intervention_name>
    <description>Single dose 60-90 min preoperatively</description>
    <arm_group_label>placebo/sodium chloride</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients having an abdominal hysterectomy on a benign indication.

          -  Patients who speak and understand Danish.

          -  Patients who can give informed consent.

        Exclusion Criteria:

          -  Diabetics

          -  Regular use of glucocorticoids, opioids or tranquilizers

          -  Regular treatment with immunosuppressives

          -  Alcohol or drug abuse

          -  Morphine intolerance

          -  Age under 18

          -  Chronic pain disease eg fibromyalgia, rheumatoid arthritis

          -  Malign indication for hysterectomy

          -  BMI over 35

          -  Decreased kidney function

          -  ASA III or IV
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Niels Jørgen Secher, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Obstetrics, Hvidovre Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Gynaechology and Obstetrics, Holbæk Sygehus</name>
      <address>
        <city>Holbæk</city>
        <zip>4300</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Lidegaard O, Hammerum MS. Landspatientregisteret til kvalitetssikring i det gynækologiske speciale. 2002.</citation>
  </reference>
  <reference>
    <citation>Danish hysterektomy database - year report 2004.</citation>
  </reference>
  <reference>
    <citation>Hall GM, Peerbhoy D, Shenkin A, Parker CJ, Salmon P. Relationship of the functional recovery after hip arthroplasty to the neuroendocrine and inflammatory responses. Br J Anaesth. 2001 Oct;87(4):537-42.</citation>
    <PMID>11878721</PMID>
  </reference>
  <reference>
    <citation>Henzi I, Walder B, Tramèr MR. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg. 2000 Jan;90(1):186-94.</citation>
    <PMID>10625002</PMID>
  </reference>
  <reference>
    <citation>Wang JJ, Ho ST, Tzeng JI, Tang CS. The effect of timing of dexamethasone administration on its efficacy as a prophylactic antiemetic for postoperative nausea and vomiting. Anesth Analg. 2000 Jul;91(1):136-9.</citation>
    <PMID>10866900</PMID>
  </reference>
  <reference>
    <citation>Liu K, Hsu CC, Chia YY. The effective dose of dexamethasone for antiemesis after major gynecological surgery. Anesth Analg. 1999 Nov;89(5):1316-8.</citation>
    <PMID>10553859</PMID>
  </reference>
  <reference>
    <citation>Kehlet H. Glucocorticoids for peri-operative analgesia: how far are we from general recommendations? Acta Anaesthesiol Scand. 2007 Oct;51(9):1133-5.</citation>
    <PMID>17850557</PMID>
  </reference>
  <reference>
    <citation>Salerno A, Hermann R. Efficacy and safety of steroid use for postoperative pain relief. Update and review of the medical literature. J Bone Joint Surg Am. 2006 Jun;88(6):1361-72. Review.</citation>
    <PMID>16757774</PMID>
  </reference>
  <reference>
    <citation>Bisgaard T, Klarskov B, Kehlet H, Rosenberg J. Preoperative dexamethasone improves surgical outcome after laparoscopic cholecystectomy: a randomized double-blind placebo-controlled trial. Ann Surg. 2003 Nov;238(5):651-60.</citation>
    <PMID>14578725</PMID>
  </reference>
  <reference>
    <citation>Romundstad L, Breivik H, Niemi G, Helle A, Stubhaug A. Methylprednisolone intravenously 1 day after surgery has sustained analgesic and opioid-sparing effects. Acta Anaesthesiol Scand. 2004 Nov;48(10):1223-31.</citation>
    <PMID>15504180</PMID>
  </reference>
  <reference>
    <citation>Nagelschmidt M, Fu ZX, Saad S, Dimmeler S, Neugebauer E. Preoperative high dose methylprednisolone improves patients outcome after abdominal surgery. Eur J Surg. 1999 Oct;165(10):971-8.</citation>
    <PMID>10574107</PMID>
  </reference>
  <reference>
    <citation>Holte K, Kehlet H. Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications. J Am Coll Surg. 2002 Nov;195(5):694-712. Review.</citation>
    <PMID>12437261</PMID>
  </reference>
  <reference>
    <citation>Sauerland S, Nagelschmidt M, Mallmann P, Neugebauer EA. Risks and benefits of preoperative high dose methylprednisolone in surgical patients: a systematic review. Drug Saf. 2000 Nov;23(5):449-61.</citation>
    <PMID>11085349</PMID>
  </reference>
  <reference>
    <citation>Mathiesen O, Rasmussen ML, Dierking G, Lech K, Hilsted KL, Fomsgaard JS, Lose G, Dahl JB. Pregabalin and dexamethasone in combination with paracetamol for postoperative pain control after abdominal hysterectomy. A randomized clinical trial. Acta Anaesthesiol Scand. 2009 Feb;53(2):227-35. doi: 10.1111/j.1399-6576.2008.01821.x. Epub 2008 Dec 6.</citation>
    <PMID>19076108</PMID>
  </reference>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 14, 2010</study_first_submitted>
  <study_first_submitted_qc>April 19, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 20, 2010</study_first_posted>
  <last_update_submitted>October 12, 2011</last_update_submitted>
  <last_update_submitted_qc>October 12, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 13, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Holbaek Sygehus</investigator_affiliation>
    <investigator_full_name>Anna Aabakke</investigator_full_name>
    <investigator_title>Anna Aabakke, M.D.</investigator_title>
  </responsible_party>
  <keyword>abdominal hysterectomy</keyword>
  <keyword>glucocorticoids</keyword>
  <keyword>rehabilitation</keyword>
  <keyword>postoperative pain</keyword>
  <keyword>analgetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

